<![CDATA[Congresso Agorà]]>https://www.agoracongress.com/blogRSS for NodeSun, 09 Aug 2026 17:51:48 GMT<![CDATA[Evidence Shapes Aesthetics: when anatomy and science guide clinical decision-making]]>https://en.agoracongress.com/post/evidence-shapes-aesthetics-anatomy-clinical-decision6a75cb164835792e8e9aa0e7Fri, 07 Aug 2026 12:17:42 GMTclaudioplebani<![CDATA[Evidence Shapes Aesthetics: quando l'anatomia e la scienza guidano la scelta clinica]]>https://www.agoracongress.com/post/evidence-shapes-aesthetics-anatomia-scelta-clinica6a75bddf7e238b0b8add00e2Fri, 07 Aug 2026 11:56:13 GMTclaudioplebani<![CDATA[Dyschromia and Pigmentation: an integrated approach with energy-based devices]]>https://en.agoracongress.com/post/dyschromia-pigmentation-energy-based-devices6a770ef3f80e149710dd2b6cSat, 08 Aug 2026 11:17:01 GMTclaudioplebani<![CDATA[Discromie e pigmentazione: un approccio integrato con le sorgenti energetiche]]>https://www.agoracongress.com/post/discromie-pigmentazione-sorgenti-energetiche6a770e67421979b2d973e727Sat, 08 Aug 2026 11:10:58 GMTclaudioplebani<![CDATA[Assessment of Botulinum Toxin Treatment in the Upper Facial Third: expert comparison]]>https://en.agoracongress.com/post/botulinum-toxin-upper-facial-third-expert-comparison6a770cd93242c62c2ba7e402Sat, 08 Aug 2026 11:07:14 GMTclaudioplebani<![CDATA[Assessment del trattamento con tossina botulinica del terzo superiore: confronto tra esperti]]>https://www.agoracongress.com/post/assessment-tossina-botulinica-terzo-superiore6a770c47421979b2d973e2d5Sat, 08 Aug 2026 11:02:03 GMTclaudioplebani<![CDATA[Facial Pigmentation and Inflammation: multimodal management of common dermatoses]]>https://en.agoracongress.com/post/facial-pigmentation-inflammation-dermatoses6a770adeffe8883586155a59Sat, 08 Aug 2026 10:59:03 GMTclaudioplebani<![CDATA[Pigmentazioni e infiammazioni del volto: gestione multimodale delle comuni dermatosi]]>https://www.agoracongress.com/post/pigmentazioni-infiammazioni-volto-dermatosi6a770a2a421979b2d973de20Sat, 08 Aug 2026 10:52:46 GMTclaudioplebani<![CDATA[PLLA, PCL, and PDO: biopolymers as threads or injectable solutions? Discussion and comparison of clinical indications and expected outcomes]]>https://en.agoracongress.com/post/plla-pcl-pdo-biopolymers-threads-injectables6a77089b3242c62c2ba7e0ccSat, 08 Aug 2026 10:49:23 GMTclaudioplebani<![CDATA[PLLA, PCL e PDO: biopolimeri sotto forma di filo o di soluzione iniettabile? Discussione e confronto rispetto a indicazioni cliniche e risultati attesi]]>https://www.agoracongress.com/post/plla-pcl-pdo-biopolimeri-fili-iniettabili6a7707cf421979b2d973d8cfSat, 08 Aug 2026 10:42:57 GMTclaudioplebani<![CDATA[Rethinking the Lips: functional anatomy and individual variation in the era of normalization]]>https://en.agoracongress.com/post/rethinking-the-lips-functional-anatomy-normalization6a77063198612c5f06a6fa23Sat, 08 Aug 2026 10:39:47 GMTclaudioplebani<![CDATA[Ripensare le labbra: anatomia funzionale e variazione individuale nell'era della normalizzazione]]>https://www.agoracongress.com/post/ripensare-le-labbra-anatomia-normalizzazione6a7705a6335316084e9e5b0dSat, 08 Aug 2026 10:33:41 GMTclaudioplebani<![CDATA[Trends in Facial Rejuvenation: skin boosting, tissue tightening, muscle relaxation, and skincare]]>https://en.agoracongress.com/post/trends-facial-rejuvenation-skin-boosting-skincare6a76d7e113bf178253fbc269Sat, 08 Aug 2026 07:21:19 GMTclaudioplebani<![CDATA[Trends nella cura del volto: skinboosting, trazione tissutale, miorilassamento e skincare]]>https://www.agoracongress.com/post/trends-cura-del-volto-skinboosting-skincare6a76d7522dc76a37da404b74Sat, 08 Aug 2026 07:16:05 GMTclaudioplebani<![CDATA[Therapeutic Strategies for the Face in the Post-Weight-Loss Patient]]>https://en.agoracongress.com/post/therapeutic-strategies-post-weight-loss-face6a76d5b1d239ea0bcd87524cSat, 08 Aug 2026 07:12:41 GMTclaudioplebani<![CDATA[Strategie terapeutiche del volto nel paziente post-dimagrimento]]>https://www.agoracongress.com/post/strategie-terapeutiche-volto-post-dimagrimento6a76d518421979b2d973698eSat, 08 Aug 2026 07:06:44 GMTclaudioplebani<![CDATA[Facial Profile and Long-Term Effects of Fillers and Toxin]]>https://en.agoracongress.com/post/facial-profile-long-term-effects-fillers-toxin6a76cf769a9195ee39253d6eSat, 08 Aug 2026 06:46:19 GMTclaudioplebani<![CDATA[Profilo facciale ed effetti a lungo termine dei filler e della tossina botulinica]]>https://www.agoracongress.com/post/profilo-facciale-effetti-lungo-termine-filler-tossina6a76cedb2dc76a37da4037b5Sat, 08 Aug 2026 06:40:09 GMTclaudioplebani<![CDATA[The Lower Third at 360°: multidisciplinary framework and integrated corrective strategies]]>https://en.agoracongress.com/post/lower-third-360-multidisciplinary-strategies6a76cd1a3242c62c2ba7b8bcSat, 08 Aug 2026 06:36:10 GMTclaudioplebani<![CDATA[Il terzo inferiore del volto a 360°: inquadramento multidisciplinare e strategie correttive integrate]]>https://www.agoracongress.com/post/terzo-inferiore-volto-360-strategie-integrate6a76bf1c421979b2d973380dSat, 08 Aug 2026 06:30:08 GMTclaudioplebani